ArticleCellular oncology (Dordrecht, Netherlands)2022

AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.

Abdulmelik Aytatli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.